Maria Adelaida García-Gimeno

Author

Instituto de Biomedicina de Valencia ORCID

Also Known As

Garcia-Gimeno, Maria Adelaida, M García-Gimeno, M. Adelaida Garcia-Gimeno, M. Adelaida García-Gimeno, M. García-Gimeno, M.A. Garcia-Gimeno, Maria A. García-Gimeno, Maria A. García-Gimeno, Maria Adelaida Garcia-Gimeno, Maria Adelaida Garcia‐Gimeno

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Instituto de Biomedicina de Valencia Centre for Biomedical Network Research on Rare Diseases Centro de Investigación Biomédica en Red Universitat Politècnica de València Consejo Superior de Investigaciones Científicas

About

Maria Adelaida García-Gimeno is an author at Instituto de Biomedicina de Valencia specializing in medicine, natural sciences, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	769
2	Natural Sciences	10	10	576
3	Biochemistry	9	9	460
4	Social Sciences	2	2	119
5	Health Sciences	1	1	14

Maria Adelaida García-Gimeno

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Severe Persistent Hyperinsulinemic Hypoglycemia due to a De Novo Glucokinase Mutation Antonio L. Cuesta‐Muñoz, Hanna Huopio, Timo Otonkoski, Diabetes	2004	192
Frataxin interacts functionally with mitochondrial electron transport chain proteins Pilar González‐Cabo, Rafael P. Vázquez‐Manrique, Maria Adelaida García-Gimeno, Human Molecular Genetics Mitochondrial BiogenesisMitochondrial FunctionBiochemistryNatural SciencesMitochondrial Dynamic	2005	139
Metformin treatment reduces motor and neuropsychiatric phenotypes in the zQ175 mouse model of Huntington disease Ana Sanchís, Maria Adelaida García-Gimeno, Antonio José Cañada Martínez, Experimental & Molecular Medicine	2019	95
Aca1 and Aca2, ATF/CREB Activators in <i>Saccharomyces cerevisiae</i>, Are Important for Carbon Source Utilization but Not the Response to Stress Maria Adelaida García-Gimeno, Kevin Struhl Molecular and Cellular Biology Molecular RegulationGeneticsMolecular BiologyCarbon Source UtilizationAca2-dependent Transcription	2000	75
Molecular Characterization of Ypi1, a Novel Saccharomyces cerevisiae Type 1 Protein Phosphatase Inhibitor Maria Adelaida García-Gimeno, Iván Muñoz, Joaquı́n Ariño, Journal of Biological Chemistry	2003	74
An Attachment-Independent Biochemical Timer of the Spindle Assembly Checkpoint Junbin Qian, Maria Adelaida García-Gimeno, Monique Beullens, Molecular Cell Cell DivisionNatural SciencesMacromolecular MachineDna ReplicationMolecular Biology	2017	74
The PP1-R6 protein phosphatase holoenzyme is involved in the glucose-induced dephosphorylation and inactivation of AMP-activated protein kinase, a key regulator of insulin secretion, in MIN6 β cells Luisa García-Haro, Maria Adelaida García-Gimeno, Dietbert Neumann, The FASEB Journal Min6 β CellsMolecular RegulationAmpk ActivityCellular PhysiologyInsulin Signaling	2010	70
A Complex of Catalytically Inactive Protein Phosphatase-1 Sandwiched between Sds22 and Inhibitor-3 Bart Lesage, Monique Beullens, Leda Pedelini, Biochemistry Protein FunctionSignal TransductionBiochemistryProtein AssemblyNatural Sciences	2007	65
Neuroinflammation and Epilepsy: From Pathophysiology to Therapies Based on Repurposing Drugs Pascual Sanz, Teresa Rubio, Maria Adelaida García-Gimeno International Journal of Molecular Sciences ImmunologyNeurological ProgressRepurposing DrugsPharmacotherapySocial Sciences	2024	62
Astrocytes: new players in progressive myoclonus epilepsy of Lafora type Carla Rubio-Villena, Rosa Viana, Jose Bonet, Human Molecular Genetics Neurological DisorderProgressive Myoclonus EpilepsyNeurochemical BiomarkersCellular NeurobiologySocial Sciences	2018	57

Page 1